Latest amyloidosis Stories
Richmond Pharmacology enrols first patient Worldwide LONDON, March 27, 2015 /PRNewswire/ -- Working in collaboration with the National Amyloidosis Centre at the
Issues Concerning Athletes proudly announces its hosting of the #Speedheals Celebrity Bartender Night, a benefit supporting the fight against Amyloidosis and support for children enduring cancer
DALLAS, March 10, 2015 /PRNewswire/ -- The Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference will bring together
CARLSBAD, Calif., March 2, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
SAN DIEGO, Dec.
SAN DIEGO, Dec. 1, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced that Joseph E.
CAMBRIDGE, Mass., Nov.
SAN DIEGO, Nov.
- LUNAR-101, an UNA(TM) oligomer therapeutic for transthyretin-mediated familial amyloid cardiomyopathy (TTR-FAC), exhibited in non-human primates TTR reduction greater than 90% with a single low dose
- Growing in low tufty patches.